Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 35 | 2021 | 5181 | 1.490 |
Why?
|
Urea | 2 | 2013 | 450 | 0.470 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2013 | 671 | 0.420 |
Why?
|
Morpholines | 1 | 2014 | 571 | 0.390 |
Why?
|
Boronic Acids | 9 | 2014 | 965 | 0.380 |
Why?
|
Phosphorylcholine | 1 | 2010 | 162 | 0.350 |
Why?
|
Pyrazines | 9 | 2014 | 1230 | 0.340 |
Why?
|
Pyrazoles | 4 | 2015 | 1972 | 0.340 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2109 | 0.300 |
Why?
|
Apoptosis | 15 | 2017 | 9727 | 0.280 |
Why?
|
Osteoblasts | 6 | 2016 | 1166 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2503 | 0.260 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2014 | 3557 | 0.260 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2017 | 2915 | 0.240 |
Why?
|
Cell Line, Tumor | 22 | 2015 | 16689 | 0.230 |
Why?
|
Sirolimus | 2 | 2014 | 1564 | 0.230 |
Why?
|
Thalidomide | 4 | 2014 | 890 | 0.230 |
Why?
|
Oligopeptides | 3 | 2015 | 1189 | 0.220 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2013 | 2948 | 0.220 |
Why?
|
Antineoplastic Agents | 9 | 2015 | 13695 | 0.210 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2015 | 434 | 0.210 |
Why?
|
Osteoclasts | 5 | 2014 | 729 | 0.200 |
Why?
|
Mice, SCID | 11 | 2016 | 2716 | 0.190 |
Why?
|
Pyrimidines | 4 | 2015 | 2942 | 0.190 |
Why?
|
Hydroxamic Acids | 2 | 2015 | 494 | 0.190 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2014 | 11524 | 0.180 |
Why?
|
Activins | 2 | 2013 | 208 | 0.180 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2015 | 789 | 0.170 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7722 | 0.170 |
Why?
|
Signal Transduction | 8 | 2017 | 23403 | 0.170 |
Why?
|
Osteolysis | 2 | 2011 | 270 | 0.160 |
Why?
|
Bone Marrow Cells | 6 | 2012 | 2513 | 0.160 |
Why?
|
Histone Deacetylases | 2 | 2013 | 728 | 0.150 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1676 | 0.150 |
Why?
|
Drug Synergism | 5 | 2015 | 1792 | 0.140 |
Why?
|
Bone Remodeling | 2 | 2011 | 575 | 0.140 |
Why?
|
Decorin | 1 | 2015 | 40 | 0.130 |
Why?
|
Mice | 23 | 2016 | 81183 | 0.130 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2015 | 730 | 0.130 |
Why?
|
Plasmacytoma | 2 | 2014 | 183 | 0.130 |
Why?
|
Cell Proliferation | 9 | 2014 | 10481 | 0.130 |
Why?
|
Casein Kinase Ialpha | 1 | 2014 | 27 | 0.120 |
Why?
|
Chemokine CCL3 | 2 | 2011 | 83 | 0.120 |
Why?
|
Enzyme Activation | 5 | 2012 | 3701 | 0.120 |
Why?
|
Phosphorylation | 4 | 2014 | 8436 | 0.120 |
Why?
|
Cell Survival | 6 | 2015 | 5882 | 0.110 |
Why?
|
Stromal Cells | 7 | 2013 | 1355 | 0.110 |
Why?
|
Tumor Microenvironment | 2 | 2016 | 3586 | 0.110 |
Why?
|
Antibodies, Neutralizing | 2 | 2013 | 1978 | 0.110 |
Why?
|
Genes, ras | 1 | 2015 | 690 | 0.110 |
Why?
|
Cyclohexanones | 1 | 2012 | 30 | 0.110 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2014 | 215 | 0.110 |
Why?
|
Benzamides | 2 | 2015 | 1379 | 0.110 |
Why?
|
Down-Regulation | 5 | 2011 | 3002 | 0.100 |
Why?
|
Acrylamides | 1 | 2014 | 255 | 0.100 |
Why?
|
Bone Diseases | 1 | 2016 | 416 | 0.100 |
Why?
|
Epoxy Compounds | 1 | 2012 | 136 | 0.100 |
Why?
|
Receptors, CCR1 | 2 | 2011 | 33 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 4 | 2013 | 5535 | 0.100 |
Why?
|
MAP Kinase Signaling System | 2 | 2015 | 1526 | 0.100 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3703 | 0.100 |
Why?
|
Imidazoles | 3 | 2015 | 1206 | 0.100 |
Why?
|
Plasma Cells | 1 | 2014 | 591 | 0.090 |
Why?
|
Animals | 24 | 2016 | 168757 | 0.090 |
Why?
|
Calcification, Physiologic | 1 | 2011 | 169 | 0.090 |
Why?
|
Osteocalcin | 1 | 2011 | 273 | 0.090 |
Why?
|
Endoribonucleases | 1 | 2012 | 229 | 0.090 |
Why?
|
Benzimidazoles | 2 | 2015 | 850 | 0.090 |
Why?
|
Caspases | 2 | 2010 | 928 | 0.090 |
Why?
|
Flavones | 1 | 2009 | 66 | 0.080 |
Why?
|
Neoplasm Transplantation | 4 | 2016 | 2085 | 0.080 |
Why?
|
Maytansine | 1 | 2009 | 80 | 0.080 |
Why?
|
Cerulenin | 1 | 2008 | 7 | 0.080 |
Why?
|
Prednisolone | 1 | 2009 | 334 | 0.080 |
Why?
|
Syndecan-1 | 1 | 2009 | 165 | 0.080 |
Why?
|
Interleukin-6 | 4 | 2012 | 3200 | 0.080 |
Why?
|
Melphalan | 1 | 2009 | 431 | 0.080 |
Why?
|
Azepines | 1 | 2010 | 336 | 0.080 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 430 | 0.080 |
Why?
|
Glycoproteins | 1 | 2016 | 2263 | 0.080 |
Why?
|
Veterans | 1 | 2021 | 2519 | 0.080 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2010 | 2015 | 0.080 |
Why?
|
RNA Splicing | 1 | 2012 | 907 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1797 | 0.070 |
Why?
|
Albumins | 1 | 2010 | 569 | 0.070 |
Why?
|
Cyclin D1 | 1 | 2009 | 463 | 0.070 |
Why?
|
Bone Marrow | 2 | 2015 | 2948 | 0.070 |
Why?
|
Autophagy | 2 | 2015 | 1300 | 0.070 |
Why?
|
Immunologic Factors | 2 | 2017 | 1580 | 0.070 |
Why?
|
RNA Polymerase II | 1 | 2010 | 551 | 0.070 |
Why?
|
Dexamethasone | 2 | 2010 | 1951 | 0.070 |
Why?
|
Ascorbic Acid | 1 | 2009 | 651 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2009 | 791 | 0.070 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2009 | 624 | 0.060 |
Why?
|
Humans | 37 | 2021 | 744343 | 0.060 |
Why?
|
Diphosphonates | 1 | 2009 | 623 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2455 | 0.060 |
Why?
|
Osteogenesis | 1 | 2011 | 1299 | 0.060 |
Why?
|
NF-kappa B | 1 | 2012 | 2499 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2013 | 2038 | 0.050 |
Why?
|
Cell Cycle | 4 | 2014 | 2967 | 0.050 |
Why?
|
Doxorubicin | 3 | 2015 | 2234 | 0.050 |
Why?
|
Immunoconjugates | 1 | 2009 | 901 | 0.050 |
Why?
|
Tumor Cells, Cultured | 4 | 2012 | 6314 | 0.050 |
Why?
|
Piperidines | 1 | 2010 | 1602 | 0.050 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 1524 | 0.050 |
Why?
|
Antioxidants | 1 | 2009 | 1663 | 0.050 |
Why?
|
Blotting, Western | 3 | 2017 | 5179 | 0.050 |
Why?
|
Cell Lineage | 1 | 2009 | 2504 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 1655 | 0.050 |
Why?
|
Cell Communication | 1 | 2007 | 1621 | 0.040 |
Why?
|
Bone and Bones | 1 | 2009 | 2575 | 0.040 |
Why?
|
Nanoparticles | 1 | 2010 | 1905 | 0.040 |
Why?
|
Transplantation, Heterologous | 3 | 2012 | 2382 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2011 | 8428 | 0.040 |
Why?
|
Cell Differentiation | 5 | 2014 | 11483 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2010 | 452 | 0.040 |
Why?
|
Disease Progression | 2 | 2014 | 13284 | 0.040 |
Why?
|
Transcription Factors | 2 | 2012 | 12208 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2019 | 875 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9648 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 311 | 0.030 |
Why?
|
Phagosomes | 1 | 2015 | 193 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 399 | 0.030 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2014 | 199 | 0.030 |
Why?
|
Interleukin-3 | 1 | 2014 | 444 | 0.030 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2012 | 68 | 0.030 |
Why?
|
Oxazines | 1 | 2014 | 298 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10180 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2009 | 1375 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1223 | 0.030 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9438 | 0.030 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2014 | 177 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9274 | 0.030 |
Why?
|
Benzoquinones | 1 | 2012 | 201 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2012 | 149 | 0.020 |
Why?
|
Retinal Pigment Epithelium | 1 | 2014 | 302 | 0.020 |
Why?
|
Lentivirus | 1 | 2014 | 501 | 0.020 |
Why?
|
Cell Adhesion | 2 | 2009 | 3144 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1878 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2013 | 428 | 0.020 |
Why?
|
RANK Ligand | 1 | 2012 | 326 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2012 | 320 | 0.020 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 233 | 0.020 |
Why?
|
Male | 8 | 2019 | 350118 | 0.020 |
Why?
|
Bone Resorption | 1 | 2014 | 723 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2010 | 156 | 0.020 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2010 | 175 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2009 | 55 | 0.020 |
Why?
|
Cell Line | 2 | 2014 | 15997 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 497 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29063 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2010 | 323 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2012 | 1799 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 625 | 0.020 |
Why?
|
Caspase 9 | 1 | 2008 | 188 | 0.020 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2008 | 148 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 1338 | 0.020 |
Why?
|
Caspase 8 | 1 | 2008 | 195 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2327 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2505 | 0.020 |
Why?
|
Genes, fos | 1 | 2007 | 183 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2010 | 629 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10943 | 0.020 |
Why?
|
Cell Fusion | 1 | 2007 | 297 | 0.020 |
Why?
|
Aged | 4 | 2021 | 163280 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2011 | 873 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2012 | 13033 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2008 | 647 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1706 | 0.020 |
Why?
|
Actins | 1 | 2014 | 2121 | 0.020 |
Why?
|
Cell Division | 1 | 2013 | 4568 | 0.020 |
Why?
|
Caspase 3 | 1 | 2008 | 758 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2043 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18029 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2012 | 1836 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2916 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1213 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 2009 | 704 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3158 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 19229 | 0.020 |
Why?
|
United States | 2 | 2021 | 69872 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8340 | 0.010 |
Why?
|
Bone Density Conservation Agents | 1 | 2009 | 773 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2010 | 2133 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3798 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2421 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2866 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2011 | 1632 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11366 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3920 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2849 | 0.010 |
Why?
|
Female | 5 | 2019 | 380194 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40561 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3647 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2219 | 0.010 |
Why?
|
Bone Density | 1 | 2009 | 3468 | 0.010 |
Why?
|
Adult | 3 | 2019 | 214055 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2014 | 63114 | 0.010 |
Why?
|
Cytokines | 1 | 2010 | 7322 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5217 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 9583 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5172 | 0.010 |
Why?
|
Middle Aged | 2 | 2019 | 213383 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 21827 | 0.010 |
Why?
|
Mutation | 1 | 2014 | 29786 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40075 | 0.000 |
Why?
|